Literature DB >> 23982691

Clinical utility gene card for: von Hippel-Lindau (VHL).

Jochen Decker1, Christine Neuhaus2, Fiona Macdonald3, Hiltrud Brauch4, Eamonn R Maher5.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23982691      PMCID： PMC3953906          DOI： 10.1038/ejhg.2013.180

Source DB:  PubMed          Journal:  Eur J Hum Genet        ISSN： 1018-4813            Impact factor:   4.246


× No keyword cloud information.
  18 in total

1.  Neuronal apoptosis linked to EglN3 prolyl hydroxylase and familial pheochromocytoma genes: developmental culling and cancer.

Authors:  Sungwoo Lee; Eijiro Nakamura; Haifeng Yang; Wenyi Wei; Michelle S Linggi; Mini P Sajan; Robert V Farese; Robert S Freeman; Bruce D Carter; William G Kaelin; Susanne Schlisio
Journal:  Cancer Cell       Date:  2005-08       Impact factor: 31.743

2.  Elective nephron sparing surgery should become standard treatment for small unilateral renal cell carcinoma: Long-term survival data of 216 patients.

Authors:  F Becker; S Siemer; U Humke; M Hack; M Ziegler; M Stöckle
Journal:  Eur Urol       Date:  2005-12-09       Impact factor: 20.096

3.  VHL alterations in human clear cell renal cell carcinoma: association with advanced tumor stage and a novel hot spot mutation.

Authors:  H Brauch; G Weirich; J Brieger; D Glavac; H Rödl; M Eichinger; M Feurer; E Weidt; C Puranakanitstha; C Neuhaus; S Pomer; W Brenner; P Schirmacher; S Störkel; M Rotter; A Masera; N Gugeler; H J Decker
Journal:  Cancer Res       Date:  2000-04-01       Impact factor: 12.701

Review 4.  Systemic VHL gene functions and the VHL disease.

Authors:  Hannah L Bader; Tien Hsu
Journal:  FEBS Lett       Date:  2012-04-25       Impact factor: 4.124

5.  Germline mutations in the Von Hippel-Lindau disease (VHL) gene in families from North America, Europe, and Japan.

Authors:  B Zbar; T Kishida; F Chen; L Schmidt; E R Maher; F M Richards; P A Crossey; A R Webster; N A Affara; M A Ferguson-Smith; H Brauch; D Glavac; H P Neumann; S Tisherman; J J Mulvihill; D J Gross; T Shuin; J Whaley; B Seizinger; N Kley; S Olschwang; C Boisson; S Richard; C H Lips; M Lerman
Journal:  Hum Mutat       Date:  1996       Impact factor: 4.878

6.  Identification of the von Hippel-Lindau disease tumor suppressor gene.

Authors:  F Latif; K Tory; J Gnarra; M Yao; F M Duh; M L Orcutt; T Stackhouse; I Kuzmin; W Modi; L Geil
Journal:  Science       Date:  1993-05-28       Impact factor: 47.728

7.  Von Hippel-Lindau (VHL) disease with pheochromocytoma in the Black Forest region of Germany: evidence for a founder effect.

Authors:  H Brauch; T Kishida; D Glavac; F Chen; F Pausch; H Höfler; F Latif; M I Lerman; B Zbar; H P Neumann
Journal:  Hum Genet       Date:  1995-05       Impact factor: 4.132

Review 8.  Genetic testing by cancer site: endocrine system.

Authors:  Robert Pilarski; Rebecca Nagy
Journal:  Cancer J       Date:  2012 Jul-Aug       Impact factor: 3.360

9.  Solid renal tumor severity in von Hippel Lindau disease is related to germline deletion length and location.

Authors:  Jodi K Maranchie; Anoushka Afonso; Paul S Albert; Sivaram Kalyandrug; John L Phillips; Shubo Zhou; James Peterson; Bijan M Ghadimi; Katheen Hurley; Joseph Riss; James R Vasselli; Thomas Ried; Berton Zbar; Peter Choyke; McClellan M Walther; Richard D Klausner; W Marston Linehan
Journal:  Hum Mutat       Date:  2004-01       Impact factor: 4.878

10.  Gene array of VHL mutation and hypoxia shows novel hypoxia-induced genes and that cyclin D1 is a VHL target gene.

Authors:  C C Wykoff; C Sotiriou; M E Cockman; P J Ratcliffe; P Maxwell; E Liu; A L Harris
Journal:  Br J Cancer       Date:  2004-03-22       Impact factor: 7.640
View more
  2 in total

Review 1.  Metabologenomics of Phaeochromocytoma and Paraganglioma: An Integrated Approach for Personalised Biochemical and Genetic Testing.

Authors:  Graeme Eisenhofer; Barbara Klink; Susan Richter; Jacques Wm Lenders; Mercedes Robledo
Journal:  Clin Biochem Rev       Date:  2017-04

Review 2.  DNA Methylation Dysfunction in Chronic Kidney Disease.

Authors:  Diego Ingrosso; Alessandra F Perna
Journal:  Genes (Basel)       Date:  2020-07-16       Impact factor: 4.096
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.